CXCR2 and CXCL8 regulate breast cancer progression in the TME by modulating several related pathological processes, including promoting breast cancer growth, angiogenesis, invasion, metastasis, and reducing cancer cell sensitivity to chemotherapy (99, 104, 105). Here, CXCL8 is linked to breast carcinoma.